Patents by Inventor Philip Michael Cocks

Philip Michael Cocks has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7507823
    Abstract: A method of preparation of crystalline aripiprazole monohydrate includes the use of solution enhanced dispersion by supercritical fluid. Specifically, water is introduced to a stream of supercritical fluid which is then allowed to mix with a stream including a mixture including aripiprazole and a solvent. The mixing results in the substantially simultaneous dispersion and extraction of the aripiprazole from the mixture by the supercritical fluid.
    Type: Grant
    Filed: May 6, 2005
    Date of Patent: March 24, 2009
    Assignee: Bristol-Myers Squibb Company
    Inventors: David R. Worthen, Simon Crawford Bristow, Philip Michael Cocks
  • Publication number: 20030225279
    Abstract: A process for the formation of Stavudine Polymorphic Form I from a mixture comprising Polymorphic Form I and at least one of Polymorphic Forms II and III is disclosed using the technique of Solution-Enhanced Dispersion by Supercritical Fluids (SEDS). A solution of the mixture in isopropyl alcohol/water is introduced into a particle formation vessel with a supercritical fluid under controlled temperature and pressure whereby the supercritical fluid substantially simultaneously disperses and extracts the solvent from the solution forming discrete particles of Stavudine Polymorphic Form I. A preferred supercritical fluid is carbon dioxide.
    Type: Application
    Filed: October 11, 2002
    Publication date: December 4, 2003
    Inventors: Simon Crawford Bristow, Philip Michael Cocks, Ronald Harland, Rajesh B. Gandhi